First test to screen blood donations for Zika virus wins FDA nod

Credit: CDC

The FDA today approved Roche Molecular System‘s (OTC:RHHBY) cobas Zika test, which detects Zika virus RNA in plasma specimens collected from volunteer blood donors and living organ donors.

The test is designed to be used by blood collection establishments to detect Zika virus in blood donations – not for the diagnosis of Zika virus infection in an individual.

Get the full story at our sister site, Drug Delivery Business News.

The post First test to screen blood donations for Zika virus wins FDA nod appeared first on MassDevice.

from MassDevice http://ift.tt/2hSfN6F